Cargando…
Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
Autores principales: | Tarantini, Giuseppe, Cardaioli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543693/ https://www.ncbi.nlm.nih.gov/pubmed/35920373 http://dx.doi.org/10.1002/ccd.30333 |
Ejemplares similares
-
SAPIEN 3 transcatheter heart valve in patients with borderline annulus: “stretched better than bigger?”
por: Tarantini, Giuseppe, et al.
Publicado: (2022) -
Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022) -
Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022) -
TAVR and stroke: A common evolution
por: Tarantini, Giuseppe, et al.
Publicado: (2022) -
Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair
por: Miller, Matthew S., et al.
Publicado: (2022)